Inhance 3D Velocity depicts colorcodedarterial and venous flow inbrain without administration ofcontrast media.
Inhance 3D Velocity depicts colorcoded arterial and venous flow in brain without administration of contrast media. Phase-contrast sequence, optimized to run on GE Healthcare’s high-end 3T Discovery MR750 and 1.5T Discovery MR450, is especially suited for use in patients who may be susceptible to gadolinium- linked nephrogenic systemic fibrosis. (Provided by GE Healthcare)
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.